Selected article for: "absolute lymphopenia and lymphocyte count absolute lymphopenia"
Author: Cho, Sung-Yeon; Lee, Hyeon-Jeong; Lee, Dong-Gun
Title: Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea
  • Document date: 2018_2_27
    • ID: t9tysvr8_54
    Snippet: There are little data on CRV infection in HSCT patients in Korea. In a 4-year retrospective study in the authors' HSCT center from 2007 to 2011, 67 of 1,038 HSCT patients (6.5%) had 71 cases of CRV-LRTI. RSV (43.6%) was the most common pathogen of CRV-LRTI, followed by PIV (26.8%), influenza virus (19.7%), and rhinovirus (9.9%) [127] . The overall mortality rate at day 30 after CRV-LRTI was 32.8%, and high-dose steroid usage (> 1 mg/kg/day), seve.....
    Document: There are little data on CRV infection in HSCT patients in Korea. In a 4-year retrospective study in the authors' HSCT center from 2007 to 2011, 67 of 1,038 HSCT patients (6.5%) had 71 cases of CRV-LRTI. RSV (43.6%) was the most common pathogen of CRV-LRTI, followed by PIV (26.8%), influenza virus (19.7%), and rhinovirus (9.9%) [127] . The overall mortality rate at day 30 after CRV-LRTI was 32.8%, and high-dose steroid usage (> 1 mg/kg/day), severe immunodeficiency, and lymphopenia (absolute lymphocyte count < 200 cells/mm 3 ) were significantly associated with mortality [127] . These findings are similar to the prevalence, mortality rate, and mortality-related risk factors of CRV-LRTI in Europe and the United States.

    Search related documents:
    Co phrase search for related documents
    • common pathogen and high dose steroid usage: 1
    • common pathogen and hsct patient: 1
    • common pathogen and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • common pathogen and lymphopenia severe immunodeficiency: 1
    • common pathogen and mortality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • common pathogen and retrospective study: 1, 2, 3, 4, 5, 6, 7, 8
    • common pathogen and rhinovirus influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • CRV infection and high dose: 1, 2, 3
    • CRV infection and high dose steroid usage: 1
    • CRV infection and influenza virus: 1, 2, 3
    • CRV infection and kg mg day: 1
    • CRV infection and retrospective study: 1, 2
    • high dose and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • high dose and kg mg day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • high dose and lymphopenia severe immunodeficiency: 1
    • high dose and mortality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • high dose and retrospective study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • high dose and rhinovirus influenza virus: 1, 2, 3
    • high dose steroid usage and rhinovirus influenza virus: 1